Develops drugs for neurodegenerative diseases.
Jun 2026Revenue $54.5M/yrExpenses $110M/yr
No trendCash runway ≈ 4.8 years from Jun 2026
Figures by year
When will Prothena Corp Public be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $54.5M and expenses $110M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $9.68M | $224M | −$215M |
| Dec 2024 | $135M | $290M | −$155M |
| Dec 2023 | $91.4M | $282M | −$191M |
| Dec 2022 | $53.9M | $185M | −$132M |
| Dec 2021 | $201M | $129M | $72.0M |
| Dec 2020 | $853K | $114M | −$113M |
| Dec 2019 | $814K | $86.5M | −$85.7M |
| Dec 2018 | $955K | $160M | −$159M |
| Dec 2017 | $27.5M | $183M | −$155M |
| Dec 2016 | $1.05M | $161M | −$160M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.